Sign in

CIK 0001528287

  • Non-accelerated filer
  • Smaller reporting company
  • Emerging growth company

NeuroPace Inc

Sign in to watch
Ticker
NPCE
Exchange
Nasdaq
Industry
Surgical & Medical Instruments & Apparatus
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
223550230
Phone
+1 650-237-2700
Business address
455 N. BERNARDO AVENUE, MOUNTAIN VIEW, CA, 94043
Open-market buys, last 90 days
$302,103
in 3 filings
Open-market sales, last 90 days
$0
in 0 filings

Net +$302,103. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2025-05-14 ORBIMED ADVISORS LLC 10% owner Sale −134,136 $15.83 $2.1M 3,272,199
2025-05-14 ORBIMED ADVISORS LLC 10% owner Sale −34,000 $15.94 $542K 3,238,199
2024-05-03 ORBIMED ADVISORS LLC 10% owner Sale −4,674 $14.03 $66K 3,406,335
2024-05-02 ORBIMED ADVISORS LLC 10% owner Sale −8,842 $14.01 $124K 3,411,009
2024-05-01 ORBIMED ADVISORS LLC 10% owner Sale −15,690 $14.02 $220K 3,419,851
2024-04-24 ORBIMED ADVISORS LLC 10% owner Sale −1,781 $14.06 $25K 3,435,541
2024-04-23 ORBIMED ADVISORS LLC 10% owner Sale −21,791 $14.29 $311K 3,437,322
2024-04-22 ORBIMED ADVISORS LLC 10% owner Sale −24,609 $14.05 $346K 3,459,113
2024-04-19 ORBIMED ADVISORS LLC 10% owner Sale −18,253 $14.02 $256K 3,483,722
2024-04-18 ORBIMED ADVISORS LLC 10% owner Sale −2,623 $14.06 $37K 3,501,975
2024-04-17 ORBIMED ADVISORS LLC 10% owner Sale −300 $14.15 $4K 3,504,598
2024-04-16 ORBIMED ADVISORS LLC 10% owner Sale −14,069 $14.01 $197K 3,504,898
2024-04-12 ORBIMED ADVISORS LLC 10% owner Sale −23,101 $14.42 $333K 3,518,967
2024-04-11 ORBIMED ADVISORS LLC 10% owner Sale −461,899 $14.49 $6.7M 3,542,068
2023-10-03 ORBIMED ADVISORS LLC 10% owner Sale −700 $9.02 $6K 4,003,967
2023-10-02 ORBIMED ADVISORS LLC 10% owner Sale −7,614 $9.08 $69K 4,004,667
2021-04-26 ORBIMED ADVISORS LLC 10% owner Conversion +3,777,281 4,012,281
2021-04-26 ORBIMED ADVISORS LLC 10% owner Conversion · Series A' Preferred Stock −171,895 0
2021-04-26 ORBIMED ADVISORS LLC 10% owner Conversion · Series B' Preferred Stock −3,605,386 0
2021-04-21 ORBIMED ADVISORS LLC 10% owner Purchase +235,000 $17.00 $4.0M 235,000

Page 1 of 1 · 20 trades